INTUITIVE SURGICAL INC — Director's Dealing 2023

Apr 24, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2023-04-21

Reporting Person: BARRATT CRAIG H (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-04-21	Common Stock	M	2000	$41.2578	Acquired	2000	Direct
2023-04-21	Common Stock	S	2000	$297.9186	Disposed	0	Direct
2023-04-21	Common Stock	M	2000	$41.2578	Acquired	2000	Direct
2023-04-21	Common Stock	S	2000	$297.9252	Disposed	0	Direct
2023-04-21	Common Stock	M	2000	$41.2578	Acquired	2000	Direct
2023-04-21	Common Stock	S	2000	$297.9183	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-21	Non-Qualified Stock Option (right to buy)	$41.2578	M	2000	Disposed	2024-04-24	Common Stock (2000)	Direct
2023-04-21	Non-Qualified Stock Option (right to buy)	$41.2578	M	2000	Disposed	2024-04-24	Common Stock (2000)	Direct
2023-04-21	Non-Qualified Stock Option (right to buy)	$41.2578	M	2000	Disposed	2024-04-24	Common Stock (2000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	24696	Indirect

Footnotes

F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on March 1, 2024.

F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.42 to $299.21 as follows: 384 shares at $296.42 - $297.12; 1,216 shares at $297.57 -$298.50; 400 shares at $298.58 - $299.21. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.56 to $299.20 as follows: 404 shares sold at $296.56 - 297.56; 1,201 shares sold at $297.6 - $298.59; and 395 shares sold at $298.61 - $299.20. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.42 to $299.23 as follows: 366 shares sold at $296.42 - 297.14; 1,254 shares sold at $297.52 - $298.46; 380 shares sold at $298.63 - $299.23. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F5: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.